Pediatrics
"Antibody Response to Measles Mumps Rubella Vaccine of Children with Mild Illness at the Time of Vaccination."
Published in Vaccine Weekly, April 1st, 1996
According to the authors' abstract of an article published in JAMA - Journal of the American Medical Association, "Objective: To examine the response to measles-mumps-rubella (MMR) vaccine among children with and without mild illness. Setting: Prospective cohort. Participants: A total of 386 children aged 15 to 23 months. Main Outcome Measures: Seroconversion rates to measles, mumps, and rubella in ill and well children. Setting: Six public health immunization clinics in two counties in the greater metropolitan Atlanta, Ga, area from February 1992 to April 1993. Results: Acute upper respiratory tract infection, otitis media, and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1996-04-01)
More Articles from Vaccine Weekly
- Conference Coverage (CHI Vaccines)
Microencapsulation Enhances Rotavirus Immunogenicity - Conference Coverage (CHI Vaccines)
Phase II Clinical Trials for Arthritis, Psoriasis Vaccines - Conference Coverage (CHI Vaccines)
Plant-Produced Vaccine Antigens: Safe, Cheap, and Stable - Conference Coverage (CHI Vaccines)
Virus-Like Particle Vaccines for VZV, HIV, Malaria, Hepatitis, More - Conference Coverage (IBC Hepatitis)
DNA Vaccine for HBV Would Offer Many Advantages - AIDS Therapies (Remune)
First Patients Treated in Nationwide Trial of HIV Therapy - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
